Evidence map›Paper›PMID 37314157›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

An Inter-Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation.

Feiyu Li, Qiang Chu, Zefeng Hu, Zijie Lu, Chao Fang, Gaorong Han, Yike Fu, Xiang Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. An Inter-Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Feiyu LiState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Qiang ChuTea Research Institute, College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, 310058, China.
Zefeng HuState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Zijie LuState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Chao FangState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Gaorong HanState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Yike FuState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Xiang LiState Key Laboratory of Silicon and Advanced Semiconductor Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.ORCID 0000-0002-4675-5367
Zhejiang University of Science and Technology · CNZhejiang University · CNTea Research Institute · CN

Funding

China National Intellectual Property Administration 2022100146563China Postdoctoral Science Foundation 2021M702784National Natural Science Foundation of China 51902288National Natural Science Foundation of China 52172289Provincial Key Research Program of Zhejiang Province 2020C04005
6 · The paper itself

Abstract

A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter-cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S

Indexed as

HydroxidesSaccharomyces cerevisiaeHydroxidesBaker's yeastbiohybrid materialslayered double hydroxidesmetabolismtumor therapy

Identifiers

PMID37314157
PMCPMC10427385
OpenAlexW4380577048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.